{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "discontinued_date": "07/07/2026",
      "update_type": "New",
      "initial_posting_date": "07/07/2026",
      "package_ndc": "0378-9651-32",
      "generic_name": "Travoprost Ophthalmic Solution",
      "contact_info": "877-446-3679",
      "related_info": "Discontinuation of the manufacture of the drug",
      "openfda": {
        "application_number": [
          "ANDA205050"
        ],
        "brand_name": [
          "TRAVOPROST OPHTHALMIC SOLUTION, 0.004%"
        ],
        "generic_name": [
          "TRAVOPROST OPHTHALMIC SOLUTION, 0.004%"
        ],
        "manufacturer_name": [
          "Mylan Pharmaceuticals Inc."
        ],
        "product_ndc": [
          "0378-9651"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "OPHTHALMIC"
        ],
        "substance_name": [
          "TRAVOPROST"
        ],
        "rxcui": [
          "284008"
        ],
        "spl_id": [
          "d78c5705-68ac-4363-b9ae-5facc60e2b79"
        ],
        "spl_set_id": [
          "00dc284f-fd96-423b-bb8f-b90ee13439bf"
        ],
        "package_ndc": [
          "0378-9651-32",
          "0378-9651-50"
        ],
        "nui": [
          "N0000175454",
          "M0017805"
        ],
        "pharm_class_epc": [
          "Prostaglandin Analog [EPC]"
        ],
        "pharm_class_cs": [
          "Prostaglandins [CS]"
        ],
        "unii": [
          "WJ68R08KX9"
        ]
      },
      "update_date": "07/07/2026",
      "therapeutic_category": [
        "Ophthalmology"
      ],
      "dosage_form": "Ophthalmic Solution",
      "presentation": "Travoprost, Ophthalmic Solution, 0.004%, 2.5 mL (NDC 0378-9651-32)",
      "company_name": "Mylan Pharmaceuticals Inc., a Viatris Company",
      "status": "To Be Discontinued"
    }
  ]
}